Anxiety disorders - Articles - Page 3

CLINICAL UPDATE

Using Equine-Assisted Psychotherapy

October 18, 2021

Anja Kriegeskotten, MD, Peter Parry, MBBS, and Renee Sievert, RN, MFT,

Anja Kriegeskotten, MD Psychiatrist in Australia, accredited equine therapist. Peter Parry, MBBS, consultant child and adolescent psychiatrist and senior lecturer at Flinders University in Adelaide, Australia. Renee Sievert, RN, MFT, certified equine therapist, CA. Dr. Kriegeskotten, Dr. Parry, and Ms. Sievert have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Equine therapy is becoming popular for a variety of child and adolescent mental health problems, from ADHD, anxiety disorders and PTSD to developmental challenges. In this article our experts describe the nuts and bolts of equine assisted psychotherapy, covering the research and the practicalities of these approaches.

Buspirone: Still Effective After All These Years?

February 3, 2021

Eugene Rubin, MD.

Eugene Rubin, MD. Psychiatrist in private practice, Bingham Farms, MI. Dr. Rubin has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Buspirone (Buspar) is approved for generalized anxiety disorder, but its efficacy there is often questioned. Here we find out how it stacks up against the benzos and SSRIs, and explore its off-label potential in depression, sexual dysfunction, alcoholism, traumatic brain injury, and premenstrual dysphoric disorder.

Silexan: A Novel Anxiolytic

July 30, 2020

Chris Aiken, MD.

Chris Aiken, MD. Editor-in-Chief of TCPR. Practicing psychiatrist, Winston-Salem, NC. Dr. Aiken has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This German medication outperformed paroxetine in generalized anxiety disorder and is available over the counter in the U.S.

EXPERT Q&A

Benzodiazepines: Old Medicines, New Concerns

June 10, 2020

Kenneth Morford, MD

Kenneth Morford, MD
Assistant Professor and Program Director, Collaborative Behavioral Health & Addiction Medicine in Primary Care (CHAMP) at Yale School of Medicine. Dr. Morford has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Benzodiazepine use is on the rise, and is implicated with a significant portion of opioid-related overdose deaths. Dr. Morford gives the latest on benzodiazepine prevalence and suggests strategies to employ in addiction treatment settings when working with patients who use benzodiazepines.

Is Paxil the Best SSRI for Anxiety?

August 30, 2019

Chris Aiken, MD

Chris Aiken, MD Dr. Aiken has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Paxil built its reputation as the best SSRI for anxiety, but the data suggests the opposite.

Benzodiazepines for Anxiety: Where They Fit In

May 1, 2018

Michael Posternak, MD.

Michael Posternak, MD. Psychiatrist in private practice, Boston, MA Dr. Posternak has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Benzodiazepines (BZDs) are widely used, rarely studied, and much maligned. So where exactly do they fit in today’s medication arsenal for treating anxiety? This article discusses when BZDs are appropriate and when they are not, and how to choose among the various BZDs.
But before doing so, let’s first address the elephant that always seems to be lurking in the BZD room: their addictive potential.

EXPERT Q&A

Acting Out: Is It Anxiety?

March 1, 2018

Ira Glovinsky, PhD

Ira Glovinsky, PhD. Licensed psychologist and principal at the Glovinsky Center for the Child and the Family in West Bloomfield, MI. Dr. Glovinsky has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

We are all busy clinicians, but if we pause and take note of our natural responses and learn how we typically respond to various kinds of kids, we gain a valuable tool that supports our ability to effectively and efficiently assess a child.

RESEARCH UPDATE

Can Mindfulness-Based Stress Reduction Affect Symptom Outcomes in Older Adults?

December 1, 2017

Adam Strassberg, MD.

Adam Strassberg, MD. Dr. Strassberg has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Mindfulness-based stress reduction (MBSR) is a formalized combination of mindfulness meditation, body awareness, and yoga. The technique has been shown to help with symptoms of depression and anxiety, and some preliminary small studies have hinted that it might improve both memory and anxiety/depressive symptoms in older patients.

Long-Term Outcomes in Anxiety Treatment

February 1, 2014

Anxiety disorders are among the most common psychiatric conditions in kids, and they are often predictive of future psychiatric problems. Researchers examined if effective treatment of anxiety disorders early on had positive long-term outcomes.

EXPERT Q&A

Anxiety Disorders in DSM-5 and Beyond

September 1, 2013

Daniel Pine, MD

Daniel Pine, MD

Chief, Section on Development and Affective Neuroscience, National Institute of Mental Health, Chair, DSM-5 Work Group on Child and Adolescent Psychiatric Disorders Dr. Pine has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.

Dr Daniel Pine, chief of the section on Development and Affective Neuroscience at the NIMH and chair of the DSM-5 Work Group on Child and Adolescent Psychiatric Disorders discusses anxiety disorders in the current and future state of anxiety disorder research and practice.